HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PHX1766

an HCV protease inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Acids: 53217
  - Noncarboxylic Acids
    - Boronic Acids: 200
      - PHX1766: 1
- Boron Compounds: 91
  - Boronic Acids: 200
    - PHX1766: 1
Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - PHX1766: 1
- Boron Compounds: 91
  - Boronic Acids: 200
    - PHX1766: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Lactams: 2198
    - PHX1766: 1

Experts

1.	Boyea, Teresa: 1 article (01/2012)
2.	Bracken, Michele: 1 article (01/2012)
3.	Campbell, David: 1 article (01/2012)
4.	Guler, Hans-Peter: 1 article (01/2012)
5.	Hotho, Daphne M: 1 article (01/2012)
6.	Janssen, Harry L A: 1 article (01/2012)
7.	Li, Jianke: 1 article (01/2012)
8.	Li, Xin: 1 article (01/2012)
9.	Molenkamp, Richard: 1 article (01/2012)
10.	O'Farrell, A Marie: 1 article (01/2012)

Related Diseases

1.	Chronic Hepatitis C 01/01/2012 - "Two clinical trials investigated the safety, tolerability, pharmacokinetics and antiviral activity of PHX1766 in healthy volunteers (HV) and chronic hepatitis C patients, by use of a dose-adaptive overlapping clinical trial design. "

Related Drugs and Biologics

1.	Antiviral Agents (Antivirals)